view페이지

The MedPacto Inc. board has appointed Dr. Seong-Jin Kim as a co-chief executive officer

Aug 25, 2016PRESS RELEASESHit 397

The founder of MedPacto, Inc. Dr. Seong-Jin Kim became a co-chief executive officer. He is also a major share holder.

Attachments
Previous Collaboration with ANRT
Next MedPacto Announces Clinical Collaboration with MSD to Evaluate Vactosertib, an Investigational TGF-β Type I Receptor Inhibitor, in combination with KEYTRUDA® (pembrolizumab)